Month: July 2020

Jul 22 2020

Uncategorized

BioXcel SERENITY I & SERENITY II phase 3 trial of BXCL501 to treat schizophrenia and bipolar disorder meets primary & secondary endpoints

by Clinical Editor

No Comments

Results demonstrated that BXCL501 was well tolerated, with rapid and durable reductions in agitation. In patients with schizophrenia (SERENITY I) and a second study of bipolar disorder (SERENITY II), …

Jul 22 2020

Uncategorized

The Lifestyle Changes That Made a Difference in My Schizophrenia Treatment

by Clinical Editor

No Comments

The writer describes how making lifestyle changes —such as stopping smoking and drinking alcohol, improving his diet and exercising more — helped make his schizophrenia medication more effective.

Jul 22 2020

Uncategorized

Brain ‘signature’ could help to diagnose schizophrenia

by Clinical Editor

No Comments

People with schizophrenia and their healthy siblings share patterns of brain activity that are different from those seen in individuals with no family history of the disorder, scientists from EPFL...

Jul 21 2020

Uncategorized

Sublingual Dexmedetomidine Promising for Acute Agitation With Schizophrenia, Bipolar Disorder – Monthly Prescribing Reference

by Clinical Editor

No Comments

Sublingual Dexmedetomidine Promising for Acute Agitation With Schizophrenia, Bipolar Disorder  Monthly Prescribing Reference BioXcel Therapeutics Announces Primary and Secondary Endpoints Met in Two Pivotal Phase 3 Trials of BXCL501 for the...

Jul 21 2020

Uncategorized

85-year-old man in wheelchair suffering from dementia, schizophrenia reported missing in Houston, police say

by Clinical Editor

No Comments

Houston police are trying to find an 85-year-old man who suffers with dementia and schizophrenia after he was reported missing Monday morning. John ‘Lloyd’ Herbert was in a wheelchair when...

Jul 21 2020

Uncategorized

Low-frequency oscillations reflect aberrant tone restoration during the auditory continuity illusion in schizophrenia

by Clinical Editor

No Comments

Patients with schizophrenia (ScZ) often show impairments in auditory information processing. These impairments have been related to clinical symptoms, such as auditory hallucinations. Some researchers …

Jul 21 2020

Uncategorized

Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce Execution of Definitive Agreement and Plan of Merger for Business Combination

by Clinical Editor

No Comments

We believe Brilaroxazine (RP5063), which demonstrated efficacy and safety in a global phase 2 clinical study for schizophrenia and schizoaffective disorders, is a compelling asset which we expect will …

Jul 21 2020

Uncategorized

Records: Knife-wielding man shot by police in ’19 after calling 911 on himself has schizophrenia

by Clinical Editor

No Comments

Devin Johnson called 911, and in a calm, matter-of-fact voice, described himself, saying there was a man with a knife “acting wild, right now.” …

Jul 21 2020

Uncategorized

Brain ‘signature’ could help to diagnose schizophrenia

by Clinical Editor

No Comments

People with schizophrenia and their healthy siblings share patterns of brain activity that are different from those seen in individuals with no family history of the disorder, scientists from EPFL...

Jul 20 2020

Uncategorized

Low-frequency oscillations reflect aberrant tone restoration during the auditory continuity illusion in schizophrenia

by Clinical Editor

No Comments

Patients with schizophrenia (ScZ) often show impairments in auditory information processing. These impairments have been related to clinical symptoms, such as auditory hallucinations. Some researchers …